Terms: = Breast cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Treatment
8 results:
1. SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by gata1 deSUMOylation.
Gao Y; Wang R; Liu J; Zhao K; Qian X; He X; Liu H
Int J Biol Sci; 2022; 18(5):2186-2201. PubMed ID: 35342335
[TBL] [Abstract] [Full Text] [Related]
2. Genomic and Transcriptomic Analyses of breast cancer Primaries and Matched Metastases in AURORA, the breast International Group (BIG) Molecular Screening Initiative.
Aftimos P; Oliveira M; Irrthum A; Fumagalli D; Sotiriou C; Gal-Yam EN; Robson ME; Ndozeng J; Di Leo A; Ciruelos EM; de Azambuja E; Viale G; Scheepers ED; Curigliano G; Bliss JM; Reis-Filho JS; Colleoni M; Balic M; Cardoso F; Albanell J; Duhem C; Marreaud S; Romagnoli D; Rojas B; Gombos A; Wildiers H; Guerrero-Zotano A; Hall P; Bonetti A; Larsson KF; Degiorgis M; Khodaverdi S; Greil R; Sverrisdóttir Á; Paoli M; Seyll E; Loibl S; Linderholm B; Zoppoli G; Davidson NE; Johannsson OT; Bedard PL; Loi S; Knox S; Cameron DA; Harbeck N; Montoya ML; Brandão M; Vingiani A; Caballero C; Hilbers FS; Yates LR; Benelli M; Venet D; Piccart MJ
Cancer Discov; 2021 Nov; 11(11):2796-2811. PubMed ID: 34183353
[TBL] [Abstract] [Full Text] [Related]
3. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
4. Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in breast cancer Patients in a Phase-II Randomized Trial.
Shaashua L; Shabat-Simon M; Haldar R; Matzner P; Zmora O; Shabtai M; Sharon E; Allweis T; Barshack I; Hayman L; Arevalo J; Ma J; Horowitz M; Cole S; Ben-Eliyahu S
Clin Cancer Res; 2017 Aug; 23(16):4651-4661. PubMed ID: 28490464
[No Abstract] [Full Text] [Related]
5. Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.
Zhang D; Wang G; Wang Y
BMC Bioinformatics; 2014; 15 Suppl 2(Suppl 2):S10. PubMed ID: 24564526
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
[TBL] [Abstract] [Full Text] [Related]
7. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.
DeCensi A; Guerrieri-Gonzaga A; Gandini S; Serrano D; Cazzaniga M; Mora S; Johansson H; Lien EA; Pruneri G; Viale G; Bonanni B
Ann Oncol; 2011 Mar; 22(3):582-587. PubMed ID: 20716629
[TBL] [Abstract] [Full Text] [Related]
